View Item 

Show simple item record

Prevention and Treatment of Hemorrhagic Cystitis

dc.contributor.authorWest, Nina J.en_US
dc.date.accessioned2012-03-16T15:53:09Z
dc.date.available2012-03-16T15:53:09Z
dc.date.issued1997-07-08en_US
dc.identifier.citationWest, Nina J. (1997). "Prevention and Treatment of Hemorrhagic Cystitis." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17(4). <http://hdl.handle.net/2027.42/90047>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90047
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titlePrevention and Treatment of Hemorrhagic Cystitisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, University of Michigan, Ann Arbor, Michiganen_US
dc.identifier.pmid9250547en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90047/1/j.1875-9114.1997.tb03745.x.pdf
dc.identifier.doi10.1002/j.1875-9114.1997.tb03745.xen_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceVincente J, Rios G, Caffaratti J. Intravesical formalin for the treatment of massive hemorrhagic cystitis: retrospective review of 25 cases. Eur Urol 1990; 18: 204 – 6.en_US
dc.identifier.citedreferenceVance BJ. Hemorrhagic cystitis: failure of estrogen treatment [letter]. Urology 1990; 36: 561.en_US
dc.identifier.citedreferencePyeritz RE, Droller MJ, Bender WL, et al. An approach to the control of massive hemorrhage in cyclophosphamide‐induced cystitis by intravenous vasopressin: a case report. J Urol 1978; 120: 253 – 4.en_US
dc.identifier.citedreferenceAroney RS, Dalley DN, Levi JA. Haemorrhagic cystitis treated with epsilon‐aminocaproic acid. Med J Aust 1980; 2: 92.en_US
dc.identifier.citedreferenceWeiss JP, Neville EC. Hyperbaric oxygen: primary treatment of radiation‐induced hemorrhagic cystitis. J Urol 1989; 142: 43 – 5.en_US
dc.identifier.citedreferenceWeiss JP, Matel DM, Neville EC, et al. Primary treatment of radiation‐induced hemorrhagic cystitis with hyperbaric oxygen: 10‐year experience. J Urol 1994; 151: 1514 – 7.en_US
dc.identifier.citedreferenceNorkool DM, Hampson NB, Gibbons RP, et al. Hyperbaric oxygen therapy for radiation‐induced hemorrhagic cystitis. J. Urol. 1993; 150: 332 – 4.en_US
dc.identifier.citedreferenceWeiss JP, Boland FP, Mori H, et al. Treatment of radiation‐induced cystitis with hyperbaric oxygen. J Urol 1985; 134: 352 – 4.en_US
dc.identifier.citedreferenceSchoenrock GJ, Cianci P. Treatment of radiation cystitis with hyperbaric oxygen. Urology 1986; 27: 271 – 2.en_US
dc.identifier.citedreferenceCahan WG, Alam Y, Mackenzie RA, et al. Intractable bladder hemorrhage treated by cryosurgery: a preliminary report. J Urol 1970; 103: 606 – 11.en_US
dc.identifier.citedreferenceSneiders A, Pryor JL. Percutaneous nephrostomy drainage in the treatment of severe hemorrhagic cystitis. J Urol 1993; 150: 966 – 7.en_US
dc.identifier.citedreferenceZagoria RJ, Hodge RG, Dyer RB, et al. Percutaneous nephrostomy for treatment of intractable hemorrhagic cystitis. J Urol 1993; 149: 1449 – 51.en_US
dc.identifier.citedreferencePomer S, Karcher G, Simon W. Cutaneous ureterostomy as last resort treatment of intractable haemorrhagic cystitis following radiation. Br J Urol 1983; 55: 392 – 4.en_US
dc.identifier.citedreferenceAppleton DS, Sibley GNA, Doyle PT. Internal iliac embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol 1988; 61: 45 – 7.en_US
dc.identifier.citedreferenceAndriole GL, Yuan JJJ, Catalona WJ. Cystotomy, temporary urinary diversion and bladder packing in the management of severe cyclophosphamide‐induced hemorrhagic cystitis. J Urol 1990; 143: 1006 – 11.en_US
dc.identifier.citedreferenceHolsten P, Jacobsen K, Pedersen JF, et al. Intravesical hydrostatic pressure treatment: new method for control of bleeding from the bladder mucosa. J Urol 1973; 109: 234 – 6.en_US
dc.identifier.citedreferenceLevine LA, Richie JP. Urological complications of cyclophosphamide. J Urol 1989; 141: 1063 – 9.en_US
dc.identifier.citedreferencedeVries CR, Freiha FS. Hemorrhagic cystitis: a review. J Urol 1990; 143: 1 – 9.en_US
dc.identifier.citedreferenceWalther MM. Cystitis. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer. Principles and practice of oncology. Philadelphia: JB Lippincott, 1993: 2358 – 62.en_US
dc.identifier.citedreferenceKlein FA, Smith MJV. Urinary complications of cyclophosphamide therapy: etiology, prevention and management. South Med J 1983; 76: 1413 – 16.en_US
dc.identifier.citedreferenceDroller MJ, Saral R, Santos G. Prevention of cyclo‐phosphamide‐induced hemorrhagic cystitis. Urology 1982; 20: 256 – 8.en_US
dc.identifier.citedreferenceFrayha RA, Kuleilat M, Mufarrij A, et al. Hemorrhagic cystitis and sicca syndrome secondary to amyloidoisis in rheumatoid arthritis. J Rheumatol 1985; 2: 378 – 9.en_US
dc.identifier.citedreferenceBlock JA. Hemorrhagic cystitis complicating untreated necrotizing vasculitis. Arthritis Rheum 1993; 36: 857 – 9.en_US
dc.identifier.citedreferenceLondergan TA, Walzak MP. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation. J Urol 1994; 151: 1013 – 14.en_US
dc.identifier.citedreferenceAmbinder RF, Burns W, Forman M, et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 1986; 146: 1400 – 1.en_US
dc.identifier.citedreferenceSpach DH, Bauwens E, Myerson D, et al. Cytomegalovirus‐induced hemorrhagic cystitis following bone marrow transplantation. Clin Infect Dis 1993; 16: 142 – 4.en_US
dc.identifier.citedreferenceSencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Transplantation 1993; 56: 875 – 9.en_US
dc.identifier.citedreferenceJerkins GR, Noe HN, Hill D. Treatment of complications of cyclophosphamide cystitis. J Urol 1988; 139: 923 – 5.en_US
dc.identifier.citedreferenceRusso P. Urologic emergencies. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer. Principles and practice of oncology. Philadelphia: JB Lippincott, 1993: 2159 – 61.en_US
dc.identifier.citedreferenceFleming R, Kucera G, Webb C, et al. Schedule dependence of mesna uroprotection following high‐dose cyclophosphamide as measured by urinary free‐thiol concentration [abstr]. Proc Annu Meet Am Assoc Cancer Res 1993; 34: A1363.en_US
dc.identifier.citedreferenceLetendre L, Hoagland HC, Gertz MA. Hemorrhagic cystitis complicating bone marrow transplantation. Mayo Clin Proc 1992; 67: 128 – 30.en_US
dc.identifier.citedreferenceVose JM, Reed EC, Pippert GC, et al. Mesna compared with continuous bladder irrigation as uroprotection during high‐dose chemotherapy and transplantation: a randomized trial. J Clin Oncol 1993; 11: 1306 – 10.en_US
dc.identifier.citedreferenceShepherd JD, Pringle LE, Barnett MJ, et al. Mesna versus hyperhydration for the prevention of cyclophosphamide‐induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 1991; 9: 2016 – 20.en_US
dc.identifier.citedreferenceHenslee PJ, Parr MD, Romond EH, et al. A randomized trial to determine the prophylactic benefit of 2‐mercaptoethane sulfonate (mesna) as a uroprotector in bone marrow transplantation (BMT) [abstr]. Proc Annu Meet Am Soc Clin Oncol 1988; 7: A1155.en_US
dc.identifier.citedreferenceHows J, Mehta A, Gordon‐Smith EC. Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data). Cancer Treat Rev 1983; 10: 53 – 6.en_US
dc.identifier.citedreferenceAtkinson K, Biggs JC, Golovsky D, et al. Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients. BMJ 1991; 7: 351 – 4.en_US
dc.identifier.citedreferenceBrugieres L, Hartmann O, Travagli JP, et al. Hemorrhagic cystitis following high‐dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 1989; 7: 194 – 9.en_US
dc.identifier.citedreferenceHows JM, Mehta A, Ward L, et al. Comparison of mesna and forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Br J Cancer 1984; 50: 753 – 6.en_US
dc.identifier.citedreferenceOstroff EB, Chenault OW. Alum irrigation for the control of massive bladder hemorrhage. J Urol 1982; 128: 929 – 30.en_US
dc.identifier.citedreferenceMartin RL, Burwinkle JW. Rapid preparation of alum bladder irrigation. Hosp Pharm 1990; 25: 1025 – 7.en_US
dc.identifier.citedreferenceGoel AK, Rao MS, Bhagwat AG, et al. Intravesical irrigation with alum for the control of massive bladder hemorrhage. J Urol 1985; 133: 956 – 7.en_US
dc.identifier.citedreferenceArrizabalaga M, Extramiana J, Parra JL, et al. Treatment of massive haematuria with aluminous salts. J Urol 1987; 60: 223 – 6.en_US
dc.identifier.citedreferenceKennedy C, Snell ME, Witherow RO. Use of alum to control intractable vesical haemorrhage. Br J Urol 1984; 56: 673 – 5.en_US
dc.identifier.citedreferenceMukamel E, Lupu A, deKernion JB. Alum irrigation for severe bladder hemorrhage. J Urol 1986; 135: 784 – 5.en_US
dc.identifier.citedreferenceGaswami AK, Mahajan RK, Nath R, et al. How safe is 1% alum irrigation in controlling intractable vesical hemorrhage? J Urol 1993; 149: 264 – 7.en_US
dc.identifier.citedreferenceKavoussi LR, Gelstein LD, Andriole GL. Encephalopathy and an elevated serum aluminum level in a patient receiving intravesical alum irrigation for severe urinary hemorrhage. J Urol 1986; 136: 665 – 7.en_US
dc.identifier.citedreferenceShoskes DA, Rodzinski CA, Struthers NW, et al. Aluminum toxicity and death following intravesical alum irrigation in a patient with renal impairment. J Urol 1992; 147: 697 – 9.en_US
dc.identifier.citedreferenceLevine LA, Jarrard DF. Treatment of cyclophosphamide‐induced hemorrhagic cystitis with intravesical carboprost tromethamine. J Urol 1993; 149: 719 – 23.en_US
dc.identifier.citedreferenceLevine LA, Kranc DM. Evaluation of carboprost tromethamine in the treatment of cyclophosphamide‐induced hemorrhagic cystitis. Cancer 1990; 66: 242 – 5.en_US
dc.identifier.citedreferenceMiller LJ, Chandler SW, Ippoliti CM. Treatment of cyclophosphamide‐induced hemorrhagic cystitis with prostaglandins. Ann Pharmacother 1994; 28: 590 – 4.en_US
dc.identifier.citedreferenceTrigg ME, O'Reilly J, Rumelhart S, et al. Prostaglandin El bladder instillations to control severe hemorrhagic cystitis. J Urol 1990; 143: 92 – 4.en_US
dc.identifier.citedreferenceMohiuddin J, Prentice HG, Schey S, et al. Treatment of cyclophosphamide‐induced cystitis with prostaglandin E2 [letter]. Ann Intern Med 1994; 101: 142.en_US
dc.identifier.citedreferenceHemal AK, Vaidyanathan S, Sankaranarayanan A, et al. Control of massive vesical hemorrhage die to radiation cystitis with intravesical instillation of 15 (s) 15‐methyl prostaglandin F2‐alpha. Int J Clin Pharmacol Ther Toxicol 1988; 26: 477 – 8.en_US
dc.identifier.citedreferenceShurafa M, Shumaker E, Cronin S. Prostaglandin F2‐alpha bladder irrigation for control of intractable cyclophosphamide‐induced hemorrhagic cystitis. J Urol 1987; 137: 1230 – 1.en_US
dc.identifier.citedreferenceIppoliti C, Przepiorka D, Mehra R, et al. Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology 1995; 46: 811 – 15.en_US
dc.identifier.citedreferenceLaslo D, Bosi A, Guidi S, et al. Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after bone marrow transplantation. Haematology 1995; 80: 421 – 5.en_US
dc.identifier.citedreferenceRaghavaiah NV, Soloway MS. Anuria following silver nitrate irrigation for intractable bladder hemorrhage. J Urol 1977; 118: 681 – 2.en_US
dc.identifier.citedreferenceKumar APM, Wren EL, Jayalakshmamma B, et al. Silver nitrate irrigation to control bladder hemorrhage in children receiving cancer therapy. J Urol 1976; 116: 85 – 6.en_US
dc.identifier.citedreferenceJerkins GR, Noe HN, Hill DE. An unusual complication of silver nitrate treatment of hemorrhagic cystitis: case report. J Urol 1986; 136: 456 – 8.en_US
dc.identifier.citedreferenceShrom SH, Donaldson MH, Duckett JW, et al. Formalin treatment for intractable hemorrhagic cystitis. A review of the literature with 16 additional cases. Cancer 1976; 38: 1785 – 9.en_US
dc.identifier.citedreferenceKumar S, Rosen P, Grabstald H. Intravesical formalin for the control of intractable bladder hemorrhage secondary to cystitis or cancer. J Urol 1975; 114: 540 – 3.en_US
dc.identifier.citedreferenceDewan AK, Mohan GM, Ravi R. Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix. Int J Gynaecol Obstet 1993; 42: 131 – 5.en_US
dc.identifier.citedreferenceDonahue LA, Frank IN. Intravesical formalin for hemorrhagic cystitis: analysis of therapy. J Urol 1989; 141: 809 – 12.en_US
dc.identifier.citedreferenceSpiro LH, Hecht H, Horowitz A, et al. Formalin treatment for massive bladder hemorrhage. Urology 1973; 2: 669 – 71.en_US
dc.identifier.citedreferenceGislason T, Noronha RF. Open instillation of formalin for hemorrhagic cystitis in a child. Urology 1981; 18: 496 – 7.en_US
dc.identifier.citedreferenceFair WR. Formalin in the treatment of massive bladder hemorrhage. Urology 1974; 3: 573 – 6.en_US
dc.identifier.citedreferenceMcGuire EJ, Weiss RM, Schiff RM, et al. Hemorrhagic radiation cystitis. Treatment. Urology 1974; 3: 204 – 8.en_US
dc.identifier.citedreferenceGodec CJ, Gleich P. Intractable hematuria and formalin. J Urol 1983; 130: 688 – 91.en_US
dc.identifier.citedreferenceServadio C, Nissenkorn I. Massive hematuria successfully treated by bladder irrigations with formalin solution. Cancer 1976; 37: 900 – 2.en_US
dc.identifier.citedreferenceGarat JM, Martinez E, Aragona F. Open instillation of formalin for cyclophosphamide‐induced hemorrhagic cystitis in a child. Eur Urol 1985; 11: 192 – 4.en_US
dc.identifier.citedreferenceBelis JA, Milam DF. Treatment of hemorrhagic radiation cystitis with formalin. W V Med J 1976; 72: 31 – 5.en_US
dc.identifier.citedreferenceEfros MD, Ahmed T, Coombe N, et al. Urologic complications of high‐dose chemotherapy and bone marrow transplantation. Urology 1994; 43: 355 – 60.en_US
dc.identifier.citedreferenceRedman JF, Kletzel M. Cutaneous vesicostomy with direct intravesical application of formalin: management of severe vesical hemorrhage resulting from high dose cyclophosphamide in boys. J Urol 1994; 151: 1048 – 50.en_US
dc.identifier.citedreferenceBenham K, Patil UB, Mariano E. Intravesical instillation of formalin for hemorrhagic cystitis secondary to radiation for gynecologic malignancies. Gynecol Oncol 1983; 16: 31 – 3.en_US
dc.identifier.citedreferenceShah BC, Albert DJ. Intravesical instillation of formalin for the management of intractable hematuria. J Urol 1973; 110: 519 – 20.en_US
dc.identifier.citedreferenceDuckett JW, Peters PC, Donaldson MH. Severe cyclophosphamide hemorrhagic cystitis controlled with phenol. J Pediatr Surg 1973; 8: 55 – 7.en_US
dc.identifier.citedreferenceLiu YK, Kosfeld RE, Marcum SG. Treatment of uraemic bleeding with conjugated oestrogen. Lancet 1984; 2: 887 – 9.en_US
dc.identifier.citedreferenceLiu YK, Flaharty JI, Steinbock GE, et al. Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol 1990; 144: 41 – 3.en_US
dc.identifier.citedreferenceMiller J, Burfield GD, Moretti KL. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol 1994; 151: 1348 – 50.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1875-9114.1997.tb03745.x.pdf
Size:
1.018MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.